Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01130207
NCT01130207
Completed
Not Applicable

Effects of Bariatric Surgery on the Gastro-intestinal Microflora

State University of New York - Upstate Medical University1 site in 1 country34 target enrollmentMay 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsObesityDiabetesPeriodontal Disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
State University of New York - Upstate Medical University
Enrollment
34
Locations
1
Primary Endpoint
Changes in microflora after bariatric surgery
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The investigators will study people who are obese and will be treated by bariatric surgery. The investigators will test the hypothesis that some of the features of obesity are related to the bacteria in the gastro-intestinal tract.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
August 2013
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
State University of New York - Upstate Medical University
Responsible Party
Principal Investigator
Principal Investigator

Edward J. Shillitoe

Professor

State University of New York - Upstate Medical University

Eligibility Criteria

Inclusion Criteria

  • •Ages 18-65
  • •Will undergo bariatric surgery for treatment of obesity in Syracuse NY
  • •Willingness to participate

Exclusion Criteria

  • •Any previous gastrointestinal surgery
  • •Use of antibiotics in the previous 3 months

Outcomes

Primary Outcomes

Changes in microflora after bariatric surgery

Time Frame: Six months

Specific differences were measured in oral and intestinal bacteria immediately after surgery.

Study Sites (1)

Loading locations...

Similar Trials

Terminated
Not Applicable
Impact of bariatric surgery on the use of medicines and the quality of life of obese patientsObesityQuality of lifeMedication useE02.319
RBR-3czdjv7niversidade Federal do Vale do São Francisco
Completed
Phase 4
The influence of having bariatric surgery on the pharmacokinetics, safety and efficacy of the novel non-nucleoside reverse transcriptase inhibitor doravirine (LABRADOR)
NL-OMON51582Afdeling Apotheek1
Active, not recruiting
Phase 1
Exposure to Doravirine in people with HIV undergoing weight loss surgeryHIV plus bariatric surgeryMedDRA version: 20.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862MedDRA version: 21.1Level: LLTClassification code 10068900Term: Bariatric surgerySystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
EUCTR2021-005347-79-NLRadboud University Medical Center8
Completed
Not Applicable
Taste Perception Pre and Post Bariatric SurgeryMorbid Obesity
NCT01536197Washington University School of Medicine33
Unknown
Not Applicable
The Effect of Bariatric Surgery to Central SensitizationBariatric SurgeryCentral Sensitization
NCT03460691Bursa Yüksek İhtisas Education and Research Hospital50